000 05532nam a22004215c 4500
999 _c7505
_d7505
001 7505
003 ES-MaUEC
005 20200714145158.0
006 a||||fo|||| 00| 0
007 cr nn 008mamaa
008 190220s2019 gw a s |||| 0|eng d
020 _a9783030041557
024 7 _a10.1007/978-3-030-04155-7
_2doi
040 _bspa
_cES-MaUEC
_dES-MaUEC
050 4 _aRC261
_b.M53 2019 EB
245 0 0 _aMicrobiome and Cancer
_cedited by Erle S. Robertson.
264 1 _aCham
_bSpringer International Publishing :
_bImprint: Humana Press
_c2019.
300 _aXIV, 401 páginas 32 ilustraciones, 24 ilustraciones a color
336 _2rdacontent
_aTexto (visual)
_btxt
337 _2rdamedia
_aelectrónico
_bc
338 _2rdacarrier
_arecurso electrónico
_bcr
347 _atext file
_bPDF
_2rda
490 1 _aCurrent Cancer Research,
_x2199-2584
490 0 _aMedicine (Springer-11650)
505 0 _aChapter 1: Microbiome and Human Malignancies -- Chapter 2: Infection based Gastric cancers -- Chapter 3: Role of Infectious agents on development of Esophageal carcinomas -- Chapter 4: Viruses and glioblastoma: affliction or opportunity -- Chapter 5: The microbiome and its contribution to skin cancer -- Chapter 6: The role of the human virome in hematologic malignancies -- Chapter 7: Association of microbes with breast cancer -- Chapter 8: The Microbiome associated with Lung Cancer -- Chapter 9: Mesothelioma and Simian Virus 40 Infection -- Chapter 10: Infections related to development of Head and Neck Cancers -- Chapter 11: Microbiota, infectious organisms and Ovarian Cancer -- Chapter 12: Hepatocellular Cancer induced by Infection -- Chapter 13: Manipulation of the Host Immune Response by Small DNA tumor Viruses -- Chapter 14: Innate immune pattern recognition and the development of intestinal cancer -- Chapter 15: Microbial Metabolites in Cancer Promotion or Prevention -- Chapter 16: Rapid Synthetic DNA vaccine development for emerging infectious disease outbreaks -- Chapter 17: Future Perspectives: Microbiome, cancer and therapeutic promise -- Index.
520 3 _aThis book ventures into a new and exciting area of discovery that directly ties our current knowledge of cancer to the discovery of microorganisms associated with different types of cancers. Recent studies demonstrate that microorganisms are directly linked to the establishment of cancers and that they can also contribute to the initiation, as well as persistence of, the cancers. Microbiome and Cancer covers the current knowledge of microbiome and its association with human cancers. It provides important reading for novices, senior undergraduates in cancer and microbiology, graduate students, junior investigators, residents, fellows and established investigators in the fields of cancer and microbiology. We cover areas related to known, broad concepts in microbiology and how they can relate to the ongoing discoveries of the micro-environment and the changes in the metabolic and physiologic states in that micro-environment, which are important for the ongoing nurturing and survival of the poly-microbial content that dictates activities in that micro-environment. We cover the interactions of microorganisms associated with gastric carcinomas, which are important for driving this particular cancer. Additional areas include oral cancers, skin cancers, ovarian cancers, breast cancers, nasopharyngeal cancers, lung cancers, mesotheliomas, Hodgkin’s and non-Hodgkin’s lymphomas, glioblastoma multiforme, hepatocellular carcinomas, as well as the inflammatory response related to the infectious agents in cancers. This book covers the metabolic changes that occur because of infection and their support for development of cancers, chronic infection and development of therapeutic strategies for detection and control of the infection. The field of microbiome research has exploded over the last five years, and we are now understanding more and more about the context in which microorganisms can contribute to the onset of cancers in humans. The field of microbiome research has demonstrated that the human body has specific biomes for tissues and that changes in these biomes at the specific organ sites can result in disease. These changes can result in dramatic differences in metabolic shifts that, together with genetic mutations, will produce the perfect niche for establishment of the particular infection programmes in that organ site. We are just beginning to understand what those changes are and how they influence the disease state. Overall, we hope to bring together the varying degrees of fluctuations in the microbiome at the major organ sites and how these changes affect the normal cellular processes because of dysregulation, leading to proliferation of the associated tissues.
650 1 4 _aCancer Research.
_0http://scigraph.springernature.com/things/product-market-codes/B11001
653 0 _aOncology.
653 0 _aMicrobiology.
700 1 _aRobertson, Erle S.
_eeditor literario
_4edt
_4http://id.loc.gov/vocabulary/relators/edt
710 2 _aSpringerLink (Online service)
_9106937
776 0 8 _iPrinted edition:
_z9783030041540
776 0 8 _iPrinted edition:
_z9783030041564
830 0 _aCurrent Cancer Research,
_x2199-2584
_9133646
856 4 0 _uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-3-030-04155-7
_zAcceso a este recurso digital (usuarios Universidad Europea de Valencia)
942 _2lcc
_cLE
998 _db